HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Genomewide linkage scan for nicotine dependence: identification of a chromosome 5 risk locus.

AbstractBACKGROUND: Nicotine dependence (ND) is costly to societies worldwide, moderately heritable, and genetically complex. Risk loci can be identified with genetic linkage analysis independent of prior physiological hypotheses. METHODS: We completed a genomewide linkage scan to map loci increasing risk for DSM-IV ND and for a quantitative assessment of ND as measured by the Fagerstrom Test for Nicotine Dependence (FTND) in a set of 634 small nuclear families ascertained on the basis of multiple individuals affected with cocaine or opioid dependence. Of these, 507 had at least two subjects affected with ND. There are two distinct populations within this sample, European-Americans (EAs) and African-Americans (AAs). RESULTS: A region on chromosome 5 was identified as containing a gene that affects risk for ND on the basis of FTND score in the AA part of our sample (logarithm of the odds [lod] score 3.04; empirically determined to be genomewide-significant, p = .0374; point p = .0001). The highest lod score observed in the EA part of the sample was on chromosome 7 (lod score 2.73). Several other "possible" risk loci were identified in either AA or EA subjects, with many of these in proximity to previously suggested risk loci from other clinical samples. Three nominally significant single-nucleotide polymorphism associations were found at the peptidylglycine alpha-amidating monooxygenase (PAM) locus under the chromosome 5 linkage peak, also in the AA part of the sample. CONCLUSIONS: These data add to the growing evidence for locations for ND risk loci, add a novel statistically significant locus important in AAs, and suggest a gene that might be contributing to this linkage signal.
AuthorsJoel Gelernter, Carolien Panhuysen, Roger Weiss, Kathleen Brady, James Poling, Michael Krauthammer, Lindsay Farrer, Henry R Kranzler (Affiliation: Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06516, USA. joel.gelernter at yale.edu)
JournalBiological psychiatry (Biol Psychiatry) Vol. 61 Issue 1 Pg. 119-26 (Jan 1 2007) ISSN: 0006-3223 [Print] United States
PMID17081504 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Multienzyme Complexes
  • Mixed Function Oxygenases
  • peptidylglycine monooxygenase
Topics
  • Chromosome Mapping (methods)
  • Chromosomes, Human, Pair 5
  • Female
  • Gene Frequency
  • Genetic Predisposition to Disease
  • Humans
  • Linkage (Genetics)
  • Lod Score
  • Male
  • Mixed Function Oxygenases (genetics)
  • Multienzyme Complexes (genetics)
  • Nuclear Family
  • Pedigree
  • Phenotype
  • Polymorphism, Single Nucleotide
  • Reproducibility of Results
  • Retrospective Studies
  • Tobacco Use Disorder (ethnology, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD